You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (106)

Journals (0)

1-10 of 106 results for anti-HER2 therapy

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database

Open access

Research article

First published 2020

Endocrine Therapy Plus Anti-HER2 Therapy as Adjuvant Systemic Therapy for Luminal HER2-Positive Breast Cancer: An Analysis of the National Cancer Database

Zeina A Nahleh, Elizabeth B Elimimian, Leah C Elson [...]

Breast Cancer: Basic and Clinical Research

Select article: Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications

Open access

Review article

First published 2022

Prognostic impact of body mass index (BMI) in HER2+ breast cancer treated with anti-HER2 therapies: from preclinical rationale to clinical implications

Francesca Ligorio, Luca Zambelli, Giovanni Fucà [...]

Therapeutic Advances in Medical Oncology

Select article: Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients

Open access

Research article

First published 2023-11

Determining the Factors Predicting the Response to Anti-HER2 Therapy in HER2-Positive Breast Cancer Patients

Ji Young You, Kyoung Hwa Park, Eun Sook Lee [...]

Cancer Control

Select article: Next-generation sequencing,should I use anti-HER2 therapy for HER2 -amplified tumors off-label? Illustrating an extrapolation framework

Open access

Research article

First published 2022

Next-generation sequencing,should I use anti-HER2 therapy for HER2 -amplified tumors off-label? Illustrating an extrapolation framework

Doah Cho, Sarah J. Lord, John Simes [...]

Therapeutic Advances in Medical Oncology

Select article: HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Open access

Review article

First published 2019

HER2-positive breast cancer: new therapeutic frontiers and overcoming resistance

Sonia Pernas, Sara M. Tolaney

Therapeutic Advances in Medical Oncology

Select article: Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer

Open access

Research article

First published 2024

Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer

Zhening Zhang, Tong Xie, Yingxuan Wang [...]

Therapeutic Advances in Medical Oncology

Select article: Pertuzumab and Trastuzumab Emtansine for Human Epidermal Growth Factor Receptor-2–Positive Metastatic Breast Cancer: Contemporary Population-Based Outcomes

Open access

Research article

First published 2019

Pertuzumab and Trastuzumab Emtansine for Human Epidermal Growth Factor Receptor-2–Positive Metastatic Breast Cancer: Contemporary Population-Based Outcomes

Sasha Lupichuk, Winson Y Cheung, Douglas Stewart

Breast Cancer: Basic and Clinical Research

Select article: Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases

Retricted access

Case report

First published 2014-4

Complete response and long-term remission to anti-HER2 combined therapy in a patient with breast cancer presented with bone marrow metastases

Mehmet Artac, Lokman Koral, Hatice Toy [...]

Journal of Oncology Pharmacy Practice

Select article: Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Open access

Review article

First published 2021

Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Huimin Lv, Min Yan, Zefei Jiang

Therapeutic Advances in Medical Oncology

Select article: Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

Free access

Review article

First published 2016-11

Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies

Laurence Lousberg, Joëlle Collignon, Guy Jerusalem

Therapeutic Advances in Medical Oncology

1
2
3
•••
11
10 / page

Article type

Publication date

Subjects

Access